Onconetix (ONCO) Research & Development (2021 - 2026)
Onconetix's Research & Development came in at $3,440 for Q2 2026, compared with -$111,670 a year earlier and down 93.2% from the prior quarter.
Powered by 
Analysis
Onconetix (ONCO) Research & Development (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Onconetix reported Research & Development of $75,340, up 307.9% year-over-year; for FY2025, it was -$66,133.
- Going back by year, Research & Development was $154,359 in FY2024 (-92.1%), $1.95 million in FY2023 (-52.8%), $4.13 million in FY2022 (+211.7%) and $1.33 million in FY2021.
- The five-year range for quarterly Research & Development is -$198,921 (Q4 2023) to $1.29 million (Q2 2022).
- The fastest year-over-year change in Research & Development over five years came in Q1 2022 (growth of 415.8%), and the weakest in Q1 2024 (a decline of 95.5%).
- Business Quant data shows ONCO's Research & Development at $50,818 (Q1 2026), $24,293 (Q4 2025) and -$3,211 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Onconetix | 1.75 Mn | -13.97 Mn | 4,303.00 | 3,440.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,440.00 |
| Mar 31, 2026 | 50,818.00 |
| Dec 31, 2025 | 24,293.00 |
| Sep 30, 2025 | -3,211.00 |
| Jun 30, 2025 | -111,670.00 |
| Mar 31, 2025 | 24,455.00 |
| Dec 31, 2024 | -3,680.00 |
| Sep 30, 2024 | 109,365.00 |
| Mar 31, 2024 | 48,964.00 |
| Dec 31, 2023 | -198,921.00 |
| Sep 30, 2023 | 219,238.00 |
| Jun 30, 2023 | 846,853.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 1.29 Mn |
| Mar 31, 2022 | 455,092.00 |
| Dec 31, 2021 | 437,326.00 |
| Sep 30, 2021 | 269,925.00 |
| Jun 30, 2021 | 529,542.00 |
API Access
Onconetix Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ONCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ONCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ONCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();